Evidence map›Paper›PMID 38427776›Full record

ArticleJournal of applied clinical medical physics2024

A radiotherapy community data-driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracy.

Fre'Etta Mae Dayo Brooks, Mallory Carson Glenn, Victor Hernandez, Jordi Saez, Hunter Mehrens, Julianne Marie Pollard-Larkin, Rebecca Maureen Howell, Christine Burns Peterson, Christopher Lee Nelson, Catharine Helen Clark and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Fre'Etta Mae Dayo BrooksUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-6611-1104
Mallory Carson GlennUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Victor HernandezDepartment of Medical Physics, Hospital Sant Joan de Reus, IISPV, Tarragona, Spain.ORCID https://orcid.org/0000-0003-3770-8486
Jordi SaezDepartment of Radiation Oncology, Hospital Clinic de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4888-9323
Hunter MehrensUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Julianne Marie Pollard-LarkinUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Rebecca Maureen HowellUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Christine Burns PetersonUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Christopher Lee NelsonUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Catharine Helen ClarkDepartment of Radiotherapy Physics, University College London Hospital London, London, UK.
Stephen Frasier KryUniversity of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · USHospital Clínic de Barcelona · ESInstitut de Recerca Biomèdica Catalunya Sud · ESUniversity College Hospital · GB

Funding

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
Correcting Dose Calculation Errors in Radiation OncologyR01CA214526 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KRY, STEPHEN F · 2017 to 2020
$594k
NCI NIH HHS CA180803NCI NIH HHS CA214526NCI NIH HHS R01 CA214526NCI NIH HHS U24 CA180803NIH HHS
6 · The paper itself

Abstract

purposeTo quantify the impact of treatment planning system beam model parameters, based on the actual spread in radiotherapy community data, on clinical treatment plans and determine which complexity metrics best describe the impact beam modeling errors have on dose accuracy.

methodsTen beam modeling parameters for a Varian accelerator were modified in RayStation to match radiotherapy community data at the 2.5, 25, 50, 75, and 97.5 percentile levels. These modifications were evaluated on 25 patient cases, including prostate, non-small cell lung, H&N, brain, and mesothelioma, generating 1,000 plan perturbations. Differences in the mean planned dose to clinical target volumes (CTV) and organs at risk (OAR) were evaluated with respect to the planned dose using the reference (50th-percentile) parameter values. Correlation between CTV dose differences, and 18 different complexity metrics were evaluated using linear regression; R-squared values were used to determine the best metric.

resultsPerturbations to MLC offset and transmission parameters demonstrated the greatest changes in dose: up to 5.7% in CTVs and 16.7% for OARs. More complex clinical plans showed greater dose perturbation with atypical beam model parameters. The mean MLC Gap and Tongue & Groove index (TGi) complexity metrics best described the impact of TPS beam modeling variations on clinical dose delivery across all anatomical sites; similar, though not identical, trends between complexity and dose perturbation were observed among all sites.

conclusionExtreme values for MLC offset and MLC transmission beam modeling parameters were found to most substantially impact the dose distribution of clinical plans and careful attention should be given to these beam modeling parameters. The mean MLC Gap and TGi complexity metrics were best suited to identifying clinical plans most sensitive to beam modeling errors; this could help provide focus for clinical QA in identifying unacceptable plans.

Indexed as

NeoplasmsOrgans at RiskParticle AcceleratorsRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedAlgorithmsHumansbeam modelingcomplexity metricsdose calculation accuracyIMRTMLCquality assuranceVMAT

Identifiers

PMID38427776
PMCPMC11087168
OpenAlexW4392363510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.